Meperidine Hydrochloride Tablet
NDC Package 64950-214-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Meperidine Hydrochloride tablets are indicated for the management of acute pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. This formulation utilizes a tablet delivery system. Marketed by Genus Lifesciences Inc., this product is identified by NDC 64950-214 and is authorized under FDA application ANDA040893.

Identification & Billing

NDC Package Code
64950-214-01
Package Description
100 TABLET in 1 BOTTLE, PLASTIC
Product Code
64950-214
11-Digit Billing Format
64950021401
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Meperidine Hydrochloride
Non-Proprietary Name
Meperidine Hydrochloride
Substance Name
Meperidine Hydrochloride
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
MEPERIDINE HYDROCHLORIDE 50 mg/1
Pharmacologic Class
Usage Information
Meperidine hydrochloride tablets are indicated for the management of acute pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate.
DEA Schedule
Schedule II (CII) Substances

Regulatory & Marketing

Labeler Name
Genus Lifesciences Inc.
Product Type
Human Prescription Drug
FDA Application #
ANDA040893
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
02-14-2024
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (64950-214). Click a package code to view its specific billing and regulatory data.

64950-214-03
30 TABLET in 1 BOTTLE, PLASTIC

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 64950-214-01 identifies a specific commercial package of 100 tablet in 1 bottle, plastic of Meperidine Hydrochloride, a human prescription drug labeled by Genus Lifesciences Inc.. This tablet is formulated for oral use and contains meperidine hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Genus Lifesciences Inc. on February 14, 2024. The current certification is valid through December 31, 2027.

How is this Genus Lifesciences Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 64950021401. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
64950-214-01
11-Digit CMS (5-4-2)
64950-0214-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.